Skip to main content

Table 1 Clinical-pathological characteristics of 913 primary PCa patients by first metastatic progression

From: The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression

Parameter
at diagnosis
No recist
progression
N (%)
First recist
progression
N (%)
P-value
Age (years)
  < 50 6 (0.8) 2 (1.5) 0.036*
  ≥ 50 and <60 106 (13.6) 29 (21.3)
  ≥ 60 and <75 570 (73.4) 97 (71.3)
  ≥ 75 and <80 80 (10.3) 8 (5.9)
  ≥ 80 15 (1.9) 0
Stage
 T1 175 (22.6) 12 (9) < 0.001*
 T2 337 (43.5) 27 (20.1)
 T3 254 (32.8) 88 (65.7)
 T4 9 (1.1) 7 (5.2)
Missing 2 2
Lymph nodes
 Negative 725 (94.4) 111 (83.5) < 0.001*
 Positive 43 (5.6) 22 (16.5)
Missing 9 3
PSA (ng/ml)
  < 10 329 (43.6) 40 (38.5) 0.001*
  ≥ 10 and <20 282 (37.3) 28 (26.9)
  > 20 144 (19.1) 36 (34.6)
Missing 22 32
Gleason Score
 3–6 238 (32) 18 (16.8) < 0.001*
 7 326 (43.8) 37 (34.6)
 8–10 180 (24.2) 52 (48.6)
Missing 33 29
Total (N) 777 136  
  1. *Significant value